Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Cell Therapy Institute, Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH), Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
Cells. 2022 Mar 10;11(6):946. doi: 10.3390/cells11060946.
Donor variation is a prominent critical issue limiting the applicability of cell-based therapies. We hypothesized that batch effects during propagation of bone marrow stromal cells (BMSCs) in human platelet lysate (hPL), replacing fetal bovine serum (FBS), can affect phenotypic and functional variability. We therefore investigated the impact of donor variation, hPL- vs. FBS-driven propagation and exhaustive proliferation, on BMSC epigenome, transcriptome, phenotype, coagulation risk and osteochondral regenerative function. Notably, propagation in hPL significantly increased BMSC proliferation, created significantly different gene expression trajectories and distinct surface marker signatures, already after just one passage. We confirmed significantly declining proliferative potential in FBS-expanded BMSC after proliferative challenge. Flow cytometry verified the canonical fibroblastic phenotype in culture-expanded BMSCs. We observed limited effects on DNA methylation, preferentially in FBS-driven cultures, irrespective of culture duration. The clotting risk increased over culture time. Moreover, expansion in xenogenic serum resulted in significant loss of function during 3D cartilage disk formation and significantly increased clotting risk. Superior chondrogenic function under hPL-conditions was maintained over culture. The platelet blood group and isoagglutinins had minor impact on BMSC function. These data demonstrate pronounced batch effects on BMSC transcriptome, phenotype and function due to serum factors, partly outcompeting donor variation after just one culture passage.
供体变异性是限制细胞疗法适用性的一个突出关键问题。我们假设在骨髓基质细胞(BMSCs)在人血小板裂解液(hPL)中增殖,替代胎牛血清(FBS)的过程中,批次效应会影响表型和功能的可变性。因此,我们研究了供体变异性、hPL-与 FBS 驱动的增殖和彻底增殖对 BMSC 表观基因组、转录组、表型、凝血风险和骨软骨再生功能的影响。值得注意的是,hPL 中的增殖显著增加了 BMSC 的增殖能力,即使只有一代,也会产生显著不同的基因表达轨迹和不同的表面标记特征。我们证实了在增殖挑战后,FBS 扩增的 BMSC 的增殖潜力显著下降。流式细胞术证实了培养扩增的 BMSCs 中的典型成纤维细胞表型。我们观察到 DNA 甲基化的影响有限,无论培养时间如何,这种影响主要存在于 FBS 驱动的培养物中。凝血风险随培养时间的延长而增加。此外,在异种血清中扩增会导致 3D 软骨盘形成过程中功能显著丧失,并显著增加凝血风险。在 hPL 条件下的优越软骨生成功能在培养过程中得以维持。血小板血型和同种凝集素对 BMSC 功能的影响较小。这些数据表明,由于血清因素,BMSC 的转录组、表型和功能存在明显的批次效应,在仅仅一个培养代后,就部分抵消了供体变异性的影响。